Wutah dodolan YoY sajrone rolas wulan kepungkur: Madrigal Corp (MDGL)

Logo grafis Madrigal Pharmaceuticals (MDGL)

Leveraging its authority in treating liver pathologies, Madrigal Pharmaceuticals (MDGL) is demonstrating growth. The year-over-year sales volume increase over the last 12 months visualizes product demand, while the 93.30 metric indicates the status of current dynamics. This confirms the successful commercialization of NASH therapy and the completion of the R&D phase with the market launch of the flagship drug Rezdiffra.

Wutah dodolan YoY sajrone rolas wulan kepungkur: Madrigal Pharma (MDGL) kanggo 11.02.2024 - 18.11.2026

Ringkesan rincian data analitis Madrigal Pharmaceuticals Inc (MDGL)

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:MDGL (Madrigal Pharma)
Produk seri Madrigal Pharmaceuticals, Inc.

This indicator measures operating revenue dynamics over the last 12 months relative to the same period last year, allowing investors to assess the pace of business scaling. Analyzing the rolling 12-month YoY revenue growth chart reveals how the commercialization of the first-in-class steatohepatitis therapy is transforming Madrigal Pharmaceuticals (MDGL) from a development stage into an active profit generation stage.

Karo sapa Madrigal Pharmaceuticals saingan

Ascendis (ASND) - Wutah pendapatan taun lumaku|CORT - Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY sajrone rolas wulan kepungkur|AKRO: Wutah dodolan YoY (TTM)|MTSR - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur MoonLake Corp|Crinetics Corp (CRNX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur newamsterdampharma.com (NAMS)|Wutah pendapatan YoY sajrone 12 wulan kepungkur soleno.life SLNO|Wutah dodolan YoY (TTM) FOLD (amicusrx.com)|Wutah pendapatan taunan sajrone rolas wulan kepungkur 89bio (ETNB)|Agios - Wutah dodolan YoY (TTM)|Structure Corp - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|mimedx.com (MDXG) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan taun lumaku RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur MBX|Wutah dodolan YoY sajrone rolas wulan kepungkur Altimmune Pharma (ALT)|Wutah dodolan YoY sajrone rolas wulan kepungkur AARD (Aardvark Therapeutics Corp)|Wutah dodolan YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Wutah pendapatan taun lumaku|BMEA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|vTv Therapeutics, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Agape ATP Corp.|Wutah pendapatan YoY sajrone 12 wulan kepungkur Pluri (PLUR)|Wutah dodolan YoY (TTM) SYBX|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)